Qube Research & Technologies LTD Acrivon Therapeutics, Inc. Transaction History

Qube Research & Technologies LTD

  • $93.8 Billion
  • Q2 2025

A detailed history of Qube Research & Technologies LTD transactions in Acrivon Therapeutics, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 12,692 shares of ACRV stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,692
Holding current value
$0
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
BUY
N/A
12,692 New
12,692 $0
Q4 2023

Feb 13, 2024
BUY
N/A
122 Added 88.41%
260 $0
Q3 2023

Nov 13, 2023
BUY
N/A
138 New
138 $0

Others Institutions Holding ACRV

# of Institutions
51
Shares Held
18.4M
Call Options Held
0
Put Options Held
0
View Full List

About Acrivon Therapeutics, Inc.

ACRV Quotes by TradingView
  • Ticker ACRV
More about ACRV
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email